KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marvell Technology (MRVL) Cash & Equivalents (2021 - 2026)

Marvell Technology (MRVL) has disclosed Cash & Equivalents for 6 consecutive years, with $72.7 million as the latest value for Q1 2026.

  • Quarterly Cash & Equivalents fell 92.33% to $72.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $72.7 million through Jan 2026, down 92.33% year-over-year, with the annual reading at $72.7 million for FY2026, 92.33% down from the prior year.
  • Cash & Equivalents hit $72.7 million in Q1 2026 for Marvell Technology, down from $2.7 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.7 billion in Q4 2025 to a low of $72.7 million in Q1 2026.
  • Historically, Cash & Equivalents has averaged $872.3 million across 5 years, with a median of $847.7 million in 2024.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 435.34% in 2022 and later tumbled 92.33% in 2026.
  • Year by year, Cash & Equivalents stood at $723.4 million in 2022, then increased by 0.3% to $725.6 million in 2023, then rose by 19.64% to $868.1 million in 2024, then skyrocketed by 212.69% to $2.7 billion in 2025, then crashed by 97.32% to $72.7 million in 2026.
  • Business Quant data shows Cash & Equivalents for MRVL at $72.7 million in Q1 2026, $2.7 billion in Q4 2025, and $1.2 billion in Q3 2025.